Therapy with direct oral anticoagulants for secondary prevention of thromboembolic events in the antiphospholipid syndrome: a systematic review and meta-analysis of randomised trials

OBJECTIVE: Antiphospholipid syndrome (APS) is a systemic autoimmune disorder characterised by venous thrombosis (VT) or arterial thrombosis (AT) and/or pregnancy morbidity and the presence of antiphospholipid antibodies. Direct oral anticoagulants (DOACs) hold several advantages to vitamin K antagon...

Descripción completa

Detalles Bibliográficos
Autores principales: Adelhelm, Josefine B H, Christensen, Robin, Balbi, Gustavo G M, Voss, Anne
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2023
Materias:
Reproductive health and APS
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10619019/
https://www.ncbi.nlm.nih.gov/pubmed/37899090
http://dx.doi.org/10.1136/lupus-2023-001018

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10619019/
https://www.ncbi.nlm.nih.gov/pubmed/37899090
http://dx.doi.org/10.1136/lupus-2023-001018

Ejemplares similares